Kyprolis 60 MG vials

Ended Awarded Last action

Contract number
SPE2DR26FN1NT
Awardee
Awarding agency
Obligated
$12,075

Award facts

Contract value 100% obligated
$12,074.94 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $12,074.94 delivery order to Amerisourcebergen Drug Corp on May 27, 2026, for 60 mg vials of Kyprolis, a specialty pharmaceutical for multiple myeloma treatment. The order is firm fixed-price with an ultimate completion date of June 17, 2026. Place of performance is Conshohocken, PA. The delivery order carries no set-aside designation and was issued under a DLA Troop Support Medical indefinite delivery contract, part of the Defense Logistics Agency's pharmaceutical prime vendor program supporting worldwide military healthcare supply.

Quick answers

Who was awarded contract SPE2DR26FN1NT?

SPE2DR26FN1NT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 27, 2026.

How much is contract SPE2DR26FN1NT worth?

The government has obligated $12,075 on SPE2DR26FN1NT.

Is contract SPE2DR26FN1NT an order under another contract?

Yes. SPE2DR26FN1NT is a delivery order under SPE2DR25D3501, an indefinite delivery contract.

Was contract SPE2DR26FN1NT competed?

The extent of competition for SPE2DR26FN1NT was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award